ResearcherSheng Jing HospitalNo recent work listed

Lingyan Jian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8234-1391; OpenAlex author ID A5006806597. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

Pharmacoeconomic Evaluation of Erlotinib for the Treatment of Pancreatic Cancer. Last author DOI 10.1016/j.clinthera.2021.04.012 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kunxi Bao · 1 shared paper, 2021 · strength 0.19
- Paper Pharmacoeconomic Evaluation of Erlotinib for the Treatment of Pancreatic Cancer. DOI 10.1016/j.clinthera.2021.04.012 ↗
Xiaobing Li · 1 shared paper, 2021 · strength 0.19
- Paper Pharmacoeconomic Evaluation of Erlotinib for the Treatment of Pancreatic Cancer. DOI 10.1016/j.clinthera.2021.04.012 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.